Weight-Loss Meds Like Wegovy, Ozempic Could Battle Alcoholism
By Dennis Thompson HealthDay Reporter
THURSDAY, Oct. 17, 2024 -- Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid addiction, a new study finds.
People taking this class of drugs, called glucagon-like peptide-1 receptor agonists (GLP-1), have a 50% lower rate of drunkenness than people with addiction disorders not on the meds, researchers reported Oct. 17 in the journal Addiction.
GLP-1 patients also have a 40% lower rate of opioid overdose, results show.
GLP-1 drugs “exhibited a strong protective association with alcohol intoxication among those with alcohol use disorder,” concluded the research team led by Fares Qeadan, an associate professor of biostatistics at Loyola University in Chicago.
“Related prescriptions additionally displayed a strong protective association with opioid overdose among individuals with opioid use disorder,” the researchers added in a journal news release.
GLP-1 drugs promote weight loss by mimicking a hormone produced in response to eating. Taking the drug helps stabilize blood sugar levels, decrease feelings of hunger and slow digestion, researchers noted.
The brain region targeted by GLP-1 “overlaps with the same processes that are responsible for the development and maintenance of addictive behaviors such as chronic substance use,” the researchers said.
For this study, researchers analyzed data on more than 500,000 people with a history of opioid addiction and 817,000 with a history of alcoholism. The data, drawn from 136 U.S. health systems, spanned January 2014 to September 2022.
Researchers tracked these folks’ use of GLP-1 drugs, as well as any bouts of intoxication or overdose they experienced.
“This study may introduce a promising new treatment for substance use disorders,” researchers said.
Sources
- Society for the Study of Addiction, news release, Oct. 17, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted October 2024
Read this next
Risk Has Doubled For Alcohol Liver Disease
THURSDAY, July 24, 2025 — Heavy-drinking Americans are more than twice as likely to develop alcohol-related liver disease compared to two decades ago, even though folks...
Summer Drinking Poses Unique And Sobering Risks
SATURDAY, July 19, 2025 — Lift a toast to summer fun but don’t let risky drinking ruin the party. Too much alcohol can be deadly in the summer heat, the...
Diabetic Women Should Be Asked About Desire For Kids At Every Doctor's Visit, Guidelines Say
FRIDAY, July 18, 2025 — Doctors should ask diabetic women at every visit about their intention to have a child, to make sure they get the appropriate care prior to...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.